This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moy, P. M. Articles by Golub, S. H. Search for Related Content PubMed PubMed Citation Articles by Moy, P. M. Articles by Golub, S. H.

Depression of Natural Killer Cytotoxic Activity in Lymphocytes Infiltrating Human Pulmonary Tumors¹

John Wayne Cancer Clinic, Division of Surgical Oncology, UCLA School of Medicine, Los Angeles, California 90024, and the Department of Surgery, Sepulveda Veterans Administration Hospital, Sepulveda, California 91306

We assessed natural killer activity of lymphocytes present at the site of human tumors to determine the local effects of the tumor on immune function. Lymphocytes were extracted from human pulmonary tumors of varying histological types. In addition to tumor-infiltrating lymphocytes (TIL), peripheral blood lymphocytes from the same patients were prepated. Using a Michaelis-Menten kinetic model and titration of K562 targets in a ⁵¹Cr release assay, TIL exhibited a marked depression of maximal lytic capacity (V_max) when compared to autologous peripheral blood lymphocytes. In a single cell lysis and binding assay to assess the proportion of target-binding lymphocytes and target-lysing binders, both TIL and peripheral blood lymphocytes had equivalent numbers of lymphocytes binding target cells and an equivalent number of target-binding cells that could mediate cytolysis. Analysis of lymphocyte subsets was performed using mouse monoclonal antibodies. The TIL population expressed markers found on natural killer cells, including HNK-1 and B73.1. Thus, natural killer cells are present at the tumor site, show lytic capability, but appear to be unable to recycle for multiple lytic events.

¹ Supported in part by USPHS Grant CA 12582.

Received 4/16/84. Accepted 9/21/84.

This article has been cited by other articles:

				S. D. Hess, N. K. Egilmez, N. Bailey, T. M. Anderson, E. Mathiowitz, S. H. Bernstein, and R. B. Bankert Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-{gamma} J. Immunol., January 1, 2003; 170(1): 400 - 412. [Abstract] [Full Text] [PDF]